Health-Related Quality of Life and Hemoglobin Levels in Chronic Kidney Disease Patients

Hospital of St Raphael, Yale University, New Haven, CT 06511, USA.
Clinical Journal of the American Society of Nephrology (Impact Factor: 4.61). 12/2008; 4(1):33-8. DOI: 10.2215/CJN.00630208
Source: PubMed


The relationship between quality of life (QofL) and anemia has been the subject of recent debates; it has been suggested that the QofL changes associated with the treatment of anemia of chronic kidney disease (CKD) or ESRD patients should not be used in making decisions to treat anemia in CKD patients.
This study examines the relationship between Kidney Disease Quality of Life (KDQofL) questionnaire domains and hemoglobin (Hgb) levels in 1200 patients with stage 3, 4, and 5 CKD followed in seven centers. QofL measures were compared in a stepwise fashion for hemoglobin levels of <11, 11 to <12, 12 to <13, and > or =13. ANOVA was used to examine the relationship between QofL scores and Hgb level, age, CKD stage, and albumin level; a history of diabetes, congestive heart failure, or myocardial infarction; use of erythropoetic-stimulating agents (ESA); and the interaction of hemoglobin level and ESA.
The results demonstrate that with increasing Hgb levels there is a statistically significant increase in all four physical domains, the energy/vitality domain, and the physical composite score of the SF-36, and the general health score on the kidney disease component of the questionnaire. The most dramatic improvements in these various domains occurred between the <11 and the 11 to 12 group.
Higher Hgb levels are associated with improved QofL domains of the KDQofL questionnaire. These findings have implications for the care of CKD patients in terms of the initiation of and the Hgb target of ESA therapy.

Download full-text


Available from: Salim Mujais,
  • Source
    • "In that study anemia was significantly associated with only 0.022 unadjusted and 0.006 lower adjusted MDS-HSI score vs. the significantly lower scores of 0.024 (unadjusted) and 0.034 (adjusted) that we found in the current study of a pool of U.S. nursing homes and utilizing a stepwise regression model. Studies outside of the LTC setting have also reported an association of anemia with HRQOL in older patients [22-24]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background Among long-term care (LTC) residents, we explored the association between anemia status and hemoglobin (Hb) level with Activities of Daily Living (ADL) functioning and health-related quality of life (HRQOL). Methods Data were derived from the AnalytiCare database, containing laboratory and Minimum Data Set (MDS) reports for 27 LTC facilities in Colorado. Study timeframe was 1/1/07-9/15/08. Patients were selected based on: residence in LTC >90 days, Hb and serum creatinine value within 90 days of the earliest non-admission (index) MDS. From the index MDS, the method of 1) Carpenter et al. [BMC Geriatrics 6:7(2006)] was used to derive a summary measure of ADL performance (the MDS-ADL score) and 2) Wodchis et al. [IJTAHC 19:3(2003)] was used to assign HRQOL scores (MDS items were mapped to the Health Utilities Index Mark 2 (HUI2) scoring function to create the MDS-HSI score). Anemia was defined as Hb <12 g/dL females and <13 g/dL males. Adjusted linear regression was used to evaluate the independent association of anemia and hemoglobin level on MDS-ADL and MDS-HSI scores. Results 838 residents met all inclusion criteria; 46% of residents were anemic. Mean (SD) MDS-ADL score was 14.9 (7.5) [0–28 scale, where higher score indicates worse functioning]. In the adjusted model, anemia was associated with a significantly worse MDS-ADL score (+1.62 points, P=.001). Residents with Hb levels 10 to <11 g/dL had significantly worse ADL score (+2.06 points, P=.005) than the >13 g/dL reference. The mean MDS-HSI score was 0.431 (0.169) [range, where 0=dead to 1=perfect health]. Compared with non-anemic residents, in this adjusted model, residents with anemia had significantly worse MDS-HSI scores (−0.034 points, P=.005). Residents with hemoglobin levels <10 g/dL had significantly worse MDS-HSI scores (−0.058 points, P=.016) than the >13 g/dL reference. Conclusions After adjusting for several covariates, LTC residents with anemia, and many of those with moderate to severe declines in Hb level, had significantly poorer outcomes in both ADL functioning and HRQOL. The association between Hb level and the HRQOL measure of MDS-HSI appears to be largely explained by the mobility domain of the HRQOL measure.
    Health and Quality of Life Outcomes 10/2012; 10(1):129. DOI:10.1186/1477-7525-10-129 · 2.12 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: th decade before the advent of dialysis and transplantation. Recently introduced enzyme replacement therapy for alpha-galactosidase deficiency is an exciting advance in the treatment of what has become a potentially treatable cause of chronic kidney disease (CKD). Even though Fabry disease is an X-linked disease, it is now appreciated that many female "carriers" become clinically affected, although generally at a later age than affected males. Major efforts are underway to understand the causes of progressive renal insuffi- ciency in Fabry disease and identify optimal adjunctive therapy (eg, antiproteinuric agents) to slow disease progression. Pedigree and population screening efforts need to be carefully considered. Nephrologists play a critical role in the diagnosis and management of Fabry disease and are the providers of dialysis and transplantation, as well as enzyme replace- ment therapy in patients identified too late in the course of the disease to prevent the development of end-stage renal disease (ESRD). Plasma alpha-Gal A activity is very low or undetectable in patients with the classic phenotype. The progressive accumulation of GL-3 and other glycosphingolipids, particularly in the vascular endothelium and smooth muscle cells, leads to multi-organ manifestations that can be lethal in the fourth or fifth decade. Patients with milder variant phenotypes have reduced, but detectable levels of plasma alpha-Gal A activity. 6-8
  • [Show abstract] [Hide abstract]
    ABSTRACT: We consider monitoring the quality of compressed video transmitted over a packet network from the perspective of a network service provider. Our focus is on no-reference methods, which assume that the original signal is not available for computing the quality estimate. We present three methods to estimate mean squared error (MSE) from the video bitstream. The first method uses only network-level measurements (like packet loss rate), the second extracts the spatio-temporal extent of the impact of the loss, and the third extracts sequence-specific information including spatio-temporal activity and the effects of error propagation. Simulation results show that the first method has the lowest complexity but the worst performance, while the third method performs best with manageable complexity.
    Signals, Systems and Computers, 2002. Conference Record of the Thirty-Sixth Asilomar Conference on; 12/2002
Show more